Imaging in lung cancer: positron emission tomography scan
JF Vansteenkiste - European Respiratory Journal, 2002 - Eur Respiratory Soc
In the past 5 yrs, positron emission tomography (PET), usually used with 18 F‐fluoro‐2‐
deoxy-glucose (FDG), has become an important imaging modality in lung cancer patients …
deoxy-glucose (FDG), has become an important imaging modality in lung cancer patients …
[HTML][HTML] PET scan in lung cancer: current recommendations and innovation
JF Vansteenkiste, SS Stroobants - Journal of Thoracic Oncology, 2006 - Elsevier
In the past 10 years, positron emission tomography (PET), usually with 18 F-fluoro-2-deoxy-
D-glucose (FDG), has become an important imaging modality in patients with lung cancer …
D-glucose (FDG), has become an important imaging modality in patients with lung cancer …
The future in diagnosis and staging of lung cancer: positron emission tomography
BM Fischer, J Mortensen - Respiration, 2006 - karger.com
Since its introduction in 1974, positron emission tomography (PET) has gained widespread
use, especially in diagnosis and staging of lung cancer. In this respect, 18F …
use, especially in diagnosis and staging of lung cancer. In this respect, 18F …
Emerging role of PET in the diagnosis and staging of lung cancer
G Coates, SJ Skehan - Canadian Respiratory Journal, 1999 - Wiley Online Library
Positron emission tomography (PET) with 18F‐fluoro‐2‐deoxyglucose (FDG) has recently
emerged as a practical and useful imaging modality in patients with lung cancer. Malignant …
emerged as a practical and useful imaging modality in patients with lung cancer. Malignant …
PET scanning in lung cancer: current status and future directions
MP Mac Manus, RJ Hicks - Seminars in surgical oncology, 2003 - Wiley Online Library
Positron emission tomography (PET) represents a dramatic advance in the imaging of lung
cancer. It is valuable for the diagnosis, staging, prognosis, and restaging of disease, and is …
cancer. It is valuable for the diagnosis, staging, prognosis, and restaging of disease, and is …
PET and PET-CT of lung cancer
HC Steinert - Positron emission tomography, 2011 - Springer
Accurate staging is essential to offer the patient the most effective available treatment and
the best estimate of prognosis. In non-small cell lung cancer (NSCLC), surgical resection …
the best estimate of prognosis. In non-small cell lung cancer (NSCLC), surgical resection …
The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology
JF Vansteenkiste, SG Stroobants - European Respiratory …, 2001 - Eur Respiratory Soc
In the past 5 yrs, positron emission tomography (PET) with 18F-fluoro-2-deoxy-d-glucose
(FDG) has become an important imaging modality in lung cancer patients. At this time, the …
(FDG) has become an important imaging modality in lung cancer patients. At this time, the …
Imaging techniques for diagnosis and staging of lung cancer
TC McLoud - Clinics in chest medicine, 2002 - chestmed.theclinics.com
Lung cancer is the leading cause of cancer mortality in the United States, with more than
170,000 individuals diagnosed each year and more than 140,000 succumbing to the …
170,000 individuals diagnosed each year and more than 140,000 succumbing to the …
Positron emission tomography scanning for the diagnosis and management of lung cancer
BR Line, CS White - Current Treatment Options in Oncology, 2004 - Springer
Opinion statement The dissemination of positron emission tomography (PET) technology
has enabled a functional approach to the evaluation of lung cancer that complements the …
has enabled a functional approach to the evaluation of lung cancer that complements the …
Lung cancer and positron emission tomography with fluorodeoxyglucose
EM Marom, JJ Erasmus, EF Patz Jr - Lung Cancer, 2000 - Elsevier
Over the past years, positron emission tomography (PET) with fluoro-2-deoxy-d-glucose
(FDG) has emerged as an important imaging modality. In the thorax, FDG-PET has been …
(FDG) has emerged as an important imaging modality. In the thorax, FDG-PET has been …